84 related articles for article (PubMed ID: 15956031)
1. Localization of alpha-dystroglycan on the podocyte: from top to toe.
Vogtländer NP; Dijkman H; Bakker MA; Campbell KP; van der Vlag J; Berden JH
J Histochem Cytochem; 2005 Nov; 53(11):1345-53. PubMed ID: 15956031
[TBL] [Abstract][Full Text] [Related]
2. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies.
Raats CJ; van den Born J; Bakker MA; Oppers-Walgreen B; Pisa BJ; Dijkman HB; Assmann KJ; Berden JH
Am J Pathol; 2000 May; 156(5):1749-65. PubMed ID: 10793086
[TBL] [Abstract][Full Text] [Related]
3. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction.
Kojima K; Davidovits A; Poczewski H; Langer B; Uchida S; Nagy-Bojarski K; Hovorka A; Sedivy R; Kerjaschki D
J Am Soc Nephrol; 2004 Aug; 15(8):2079-89. PubMed ID: 15284294
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species deglycosilate glomerular alpha-dystroglycan.
Vogtländer NP; Tamboer WP; Bakker MA; Campbell KP; van der Vlag J; Berden JH
Kidney Int; 2006 May; 69(9):1526-34. PubMed ID: 16672922
[TBL] [Abstract][Full Text] [Related]
5. Novel 13A antigen is an integral protein of the basolateral membrane of rat glomerular podocytes.
Tissari J; Holthöfer H; Miettinen A
Lab Invest; 1994 Oct; 71(4):519-27. PubMed ID: 7967507
[TBL] [Abstract][Full Text] [Related]
6. Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?
Vogtländer NP; Visch HJ; Bakker MA; Berden JH; van der Vlag J
PLoS One; 2009 Jun; 4(6):e5979. PubMed ID: 19543532
[TBL] [Abstract][Full Text] [Related]
7. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
[TBL] [Abstract][Full Text] [Related]
8. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
[TBL] [Abstract][Full Text] [Related]
9. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells.
Plaisier E; Mougenot B; Verpont MC; Jouanneau C; Archelos JJ; Martini R; Kerjaschki D; Ronco P
J Am Soc Nephrol; 2005 Nov; 16(11):3350-6. PubMed ID: 16162811
[TBL] [Abstract][Full Text] [Related]
10. Expression of sialidase and dystroglycan in human glomerular diseases.
Vogtländer NP; van der Vlag J; Bakker MA; Dijkman HB; Wevers RA; Campbell KP; Wetzels JF; Berden JH
Nephrol Dial Transplant; 2010 Feb; 25(2):478-84. PubMed ID: 19755471
[TBL] [Abstract][Full Text] [Related]
11. Processing and secretion of the N-terminal domain of alpha-dystroglycan in cell culture media.
Saito F; Saito-Arai Y; Nakamura A; Shimizu T; Matsumura K
FEBS Lett; 2008 Feb; 582(3):439-44. PubMed ID: 18201566
[TBL] [Abstract][Full Text] [Related]
12. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
13. Expression of nestin in rat and human glomerular podocytes.
Ishizaki M; Ishiwata T; Adachi A; Tamura N; Ghazizadeh M; Kitamura H; Sugisaki Y; Yamanaka N; Naito Z; Fukuda Y
J Submicrosc Cytol Pathol; 2006; 38(2-3):193-200. PubMed ID: 17784648
[TBL] [Abstract][Full Text] [Related]
14. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling.
Dai C; Stolz DB; Bastacky SI; St-Arnaud R; Wu C; Dedhar S; Liu Y
J Am Soc Nephrol; 2006 Aug; 17(8):2164-75. PubMed ID: 16837631
[TBL] [Abstract][Full Text] [Related]
15. Co-localization of fukutin and alpha-dystroglycan in the mouse central nervous system.
Ohtsuka-Tsurumi E; Saito Y; Yamamoto T; Voit T; Kobayashi M; Osawa M
Brain Res Dev Brain Res; 2004 Sep; 152(2):121-7. PubMed ID: 15351499
[TBL] [Abstract][Full Text] [Related]
16. Dystroglycan does not contribute significantly to kidney development or function, in health or after injury.
Jarad G; Pippin JW; Shankland SJ; Kreidberg JA; Miner JH
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F811-20. PubMed ID: 21209007
[TBL] [Abstract][Full Text] [Related]
17. Binding of laminin alpha1-chain LG4-5 domain to alpha-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling.
Zhou YW; Thomason DB; Gullberg D; Jarrett HW
Biochemistry; 2006 Feb; 45(7):2042-52. PubMed ID: 16475793
[TBL] [Abstract][Full Text] [Related]
18. Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome.
Dunér F; Patrakka J; Xiao Z; Larsson J; Vlamis-Gardikas A; Pettersson E; Tryggvason K; Hultenby K; Wernerson A
Nephrol Dial Transplant; 2008 Aug; 23(8):2504-11. PubMed ID: 18356187
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats.
Lai KW; Wei CL; Tan LK; Tan PH; Chiang GS; Lee CG; Jordan SC; Yap HK
J Am Soc Nephrol; 2007 May; 18(5):1476-85. PubMed ID: 17429054
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
